Current Report Filing (8-k)
November 02 2017 - 3:07PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): October 23, 2017
MEDICAL
INNOVATION HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
Colorado
|
|
000-27211
|
|
84-1469319
|
(State
or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
of
Incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
5805
State Bridge Road, Suite G-328, Duluth, Georgia 30097
(Address
of Principal Executive Offices) (Zip Code)
(866)
883-3793
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
SECTION
1 — REGISTRANT’S BUSINESS AND OPERATIONS
ITEM
1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On
October 23, 2017, Medical Innovation Holdings, Inc., a Colorado corporation (the “Company”) issued an eight percent
(8%) Convertible Promissory Note (the “Note”), Eagle Equities LLC. (“Eagle”) in the amount of seventy-five
thousand US dollars ($75,000) to evidence funds lent by Eagle to the Company on October 23, 2017. The Note provides for a maturity
date of October 23, 2018.
The
above description of the Note is intended as a summary only and is qualified in its entirety by the terms and conditions set forth
therein, and may not contain all information that is of interest to the reader. For further information regarding the terms and
conditions of the Note, this reference is made to the Note, which is filed hereto as Exhibit 10.1 and is incorporated herein by
this reference.
ITEM
2.03 CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT
The
information set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated herein by this reference.
SECTION
9 — FINANCIAL STATEMENTS AND EXHIBITS
ITEM
9.01 FINANCIAL STATEMENTS AND EXHIBITS
The
following is a complete list of exhibits filed as part of this Report.
Exhibit
numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
Medical
Innovation Holdings, Inc.
|
|
|
|
By
|
/s/
Arturo Jake Sanchez
|
|
Name:
|
Arturo
“Jake” Sanchez
|
|
Title:
|
CEO
|
Date:
November 2, 2017